KVUE Quote, Financials, Valuation and Earnings

Grove Collaborative Holdings has a net margin of 8% compared to Kenvue's net margin of -25.53%. Kenvue's return on equity of 9.84% beat Grove Collaborative Holdings's return on equity of -154.22%.

Kenvue has a consensus price target of $24.25, signalling upside risk potential of 1.56%. On the other hand Grove Collaborative Holdings has an analysts' consensus of $2.50 which suggests that it could grow by 86.57%. Given that Grove Collaborative Holdings has higher upside potential than Kenvue, analysts believe Grove Collaborative Holdings is more attractive than Kenvue.

Kenvue has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Grove Collaborative Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Kenvue has a quarterly dividend of $0.21 per share corresponding to a yield of 3.41%. Grove Collaborative Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue pays 150.68% of its earnings as a dividend. Grove Collaborative Holdings pays out -- of its earnings as a dividend.

Kenvue quarterly revenues are $3.7B, which are larger than Grove Collaborative Holdings quarterly revenues of $49.5M. Kenvue's net income of $293M is higher than Grove Collaborative Holdings's net income of -$12.6M. Notably, Kenvue's price-to-earnings ratio is 45.06x while Grove Collaborative Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue is 2.97x versus 0.24x for Grove Collaborative Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Hims & Hers Health has a net margin of 8% compared to Kenvue's net margin of 5.41%. Kenvue's return on equity of 9.84% beat Hims & Hers Health's return on equity of 32.03%.

Kenvue has a consensus price target of $24.25, signalling upside risk potential of 1.56%. On the other hand Hims & Hers Health has an analysts' consensus of $44.16 which suggests that it could grow by 42.23%. Given that Hims & Hers Health has higher upside potential than Kenvue, analysts believe Hims & Hers Health is more attractive than Kenvue.

Kenvue has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 1.654, suggesting its more volatile than the S&P 500 by 65.449%.

Kenvue has a quarterly dividend of $0.21 per share corresponding to a yield of 3.41%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue pays 150.68% of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend.

Kenvue quarterly revenues are $3.7B, which are larger than Hims & Hers Health quarterly revenues of $481.1M. Kenvue's net income of $293M is higher than Hims & Hers Health's net income of $26M. Notably, Kenvue's price-to-earnings ratio is 45.06x while Hims & Hers Health's PE ratio is 57.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue is 2.97x versus 4.98x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health has a net margin of 8% compared to Kenvue's net margin of -12.37%. Kenvue's return on equity of 9.84% beat The Beauty Health's return on equity of -47.95%.

Kenvue has a consensus price target of $24.25, signalling upside risk potential of 1.56%. On the other hand The Beauty Health has an analysts' consensus of $1.58 which suggests that it could grow by 28.05%. Given that The Beauty Health has higher upside potential than Kenvue, analysts believe The Beauty Health is more attractive than Kenvue.

Kenvue has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Kenvue has a quarterly dividend of $0.21 per share corresponding to a yield of 3.41%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue pays 150.68% of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.

Kenvue quarterly revenues are $3.7B, which are larger than The Beauty Health quarterly revenues of $83.5M. Kenvue's net income of $293M is higher than The Beauty Health's net income of -$10.3M. Notably, Kenvue's price-to-earnings ratio is 45.06x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue is 2.97x versus 0.51x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.

Sentient Brands Holdings has a net margin of 8% compared to Kenvue's net margin of --. Kenvue's return on equity of 9.84% beat Sentient Brands Holdings's return on equity of --.

Kenvue has a consensus price target of $24.25, signalling upside risk potential of 1.56%. On the other hand Sentient Brands Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Kenvue has higher upside potential than Sentient Brands Holdings, analysts believe Kenvue is more attractive than Sentient Brands Holdings.

Kenvue has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sentient Brands Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Kenvue has a quarterly dividend of $0.21 per share corresponding to a yield of 3.41%. Sentient Brands Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue pays 150.68% of its earnings as a dividend. Sentient Brands Holdings pays out -- of its earnings as a dividend.

Kenvue quarterly revenues are $3.7B, which are larger than Sentient Brands Holdings quarterly revenues of --. Kenvue's net income of $293M is higher than Sentient Brands Holdings's net income of -$291.8K. Notably, Kenvue's price-to-earnings ratio is 45.06x while Sentient Brands Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue is 2.97x versus -- for Sentient Brands Holdings. Usually stocks with elevated PS ratios are considered overvalued.